Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

In situ chemical oxidation of BTEX and MTBE by ferrate: pH dependence and stability.

Pepino Minetti RC, MacaƱo HR, Britch J, Allende MC.

J Hazard Mater. 2017 Feb 15;324(Pt B):448-456. doi: 10.1016/j.jhazmat.2016.11.010. Epub 2016 Nov 4.

PMID:
27836409
2.

CD4 cell response to 3 doses of subcutaneous interleukin 2: meta-analysis of 3 Vanguard studies.

Arduino RC, Nannini EC, Rodriguez-Barradas M, Schrader S, Losso M, Ruxrungtham K, Allende MC, Emery S, Fosdick L, Neaton J, Tavel JA, Davey RT, Lane HC; Evaluation of Subcutaneous Proleukin in a Randomized International Trial (ESPRIT) Vanguard Group; ESPRIT Executive Committee.

Clin Infect Dis. 2004 Jul 1;39(1):115-22. Epub 2004 Jun 14.

PMID:
15206062
3.

Increasing CD4+ T cells specific for tuberculosis correlate with improved clinical immunity after highly active antiretroviral therapy.

Hengel RL, Allende MC, Dewar RL, Metcalf JA, Mican JM, Lane HC.

AIDS Res Hum Retroviruses. 2002 Sep 1;18(13):969-75.

PMID:
12230939
4.

Cytokine-based therapies for HIV infection.

Allende MC, Lane HC.

AIDS. 2001;15 Suppl 5:S183-91. Review. No abstract available.

PMID:
11816167
5.

A randomized, controlled, phase II trial comparing escalating doses of subcutaneous interleukin-2 plus antiretrovirals versus antiretrovirals alone in human immunodeficiency virus-infected patients with CD4+ cell counts >/=350/mm3.

Losso MH, Belloso WH, Emery S, Benetucci JA, Cahn PE, Lasala MC, Lopardo G, Salomon H, Saracco M, Nelson E, Law MG, Davey RT, Allende MC, Lane HC.

J Infect Dis. 2000 May;181(5):1614-21. Epub 2000 May 15.

PMID:
10823761
6.

Pathogenesis of pulmonary aspergillosis. Granulocytopenia versus cyclosporine and methylprednisolone-induced immunosuppression.

Berenguer J, Allende MC, Lee JW, Garrett K, Lyman C, Ali NM, Bacher J, Pizzo PA, Walsh TJ.

Am J Respir Crit Care Med. 1995 Sep;152(3):1079-86.

PMID:
7663787
7.

Itraconazole for experimental pulmonary aspergillosis: comparison with amphotericin B, interaction with cyclosporin A, and correlation between therapeutic response and itraconazole concentrations in plasma.

Berenguer J, Ali NM, Allende MC, Lee J, Garrett K, Battaglia S, Piscitelli SC, Rinaldi MG, Pizzo PA, Walsh TJ.

Antimicrob Agents Chemother. 1994 Jun;38(6):1303-8.

8.

Dose-dependent antifungal activity and nephrotoxicity of amphotericin B colloidal dispersion in experimental pulmonary aspergillosis.

Allende MC, Lee JW, Francis P, Garrett K, Dollenberg H, Berenguer J, Lyman CA, Pizzo PA, Walsh TJ.

Antimicrob Agents Chemother. 1994 Mar;38(3):518-22.

Supplemental Content

Loading ...
Support Center